Qiagen names Filtration Group's Pratt as CEO; shares down
BUZZ-Qiagen names Filtration Group's Pratt as CEO; shares down ** U.S.-listed shares of laboratory testing solutions provider Qiagen QIA.DE, QGEN.N fall 2% to $43.31
** Co says Jonathan Pratt will take over as CEO on Sept. 1, 2026, succeeding Thierry Bernard, who will support the transition through year-end
** Pratt most recently served as CEO of Filtration Group, leading the company through its sale to Parker-Hannifin earlier this month
** Qiagen says the appointment follows a comprehensive search process and reflects Pratt's experience across the life sciences and healthcare industries
** Co reiterates its third-quarter and full-year 2026 forecast
** Adds its board continues to evaluate strategic options to create shareholder value
** Including session's move, stock down ~8% YTD
(Reporting by Sahil Pandey in Bengaluru)
Recent news on QIAGEN
See all newsLab testing LBO offers murky result for both sides
Deals of the day-Mergers and acquisitions
Press Digest: Financial Times - October 22
Brief: Qiagen And Eqt Private Equity Announce Agreement On A Recommended Voluntary All-Cash Public Takeover Offer
EQT to buy molecular testing firm Qiagen for $10.8 billion (updated)